QALY league table of Iran: a practical method for better resource allocation

• Published in: Cost effectiveness and resource allocation 2021-01, Vol.19 (1), p.3-3, Article 3
• Main Authors: Hashempour, Reza, Raei, Behzad, Safaei Lari, Majid, Abolhasanbeigi Gallezan, Nasrin, AkbariSari, Ali
• Format: Article
• Language: English
• Subjects: Autoimmune diseases; Cardiovascular diseases; Coronary heart disease; Cost analysis; Cost benefit analysis; Cost effectiveness analysis; Cost utility analysis; Decision trees; Economic evaluation; Grey literature; Health insurance; Health technology assessment; Hemophilia; Heterogeneity; Intervention; Iran; Markov chains; Markov processes; Medical research; Medicine, Experimental; Multiple sclerosis; Public health; Radiography; Resource allocation; Review; Rheumatoid arthritis; Rheumatoid factor; Sensitivity analysis
• ISSN: 1478-7547; 1478-7547
• DOI: 10.1186/s12962-020-00256-2

The limited health care resources cannot meet all the demands of the society. Thus, decision makers have to choose feasible interventions and reject the others. We aimed to collect and summarize the results of all cost utility analysis studies that were conducted in Iran and develop a Quality Adjusted Life Year (QALY) league table. A systematic mapping review was conducted to identify all cost utility analysis studies done in Iran and then map them in a table. PubMed, Embase, Cochrane library, Web of Science, as well as Iranian databases like Iran Medex, SID, Magiran, and Barakat Knowledge Network System were all searched for articles published from the inception of the databases to January 2020. Additionally, Cost per QALY or Incremental Cost Utility Ratio (ICUR) were collected from all studies. The Joanna Briggs checklist was used to assess quality appraisal. In total, 51 cost-utility studies were included in the final analysis, out of which 14 studies were on cancer, six studies on coronary heart diseases. Two studies, each on hemophilia, multiple sclerosis and rheumatoid arthritis. The rest were on various other diseases. Markov model was the commonest one which has been applied to in 45% of the reviewed studies. Discount rates ranged from zero to 7.2%. The cost per QALY ranged from $ 0.144 in radiography costs for patients with some orthopedic problems to $ 4,551,521 for immune tolerance induction (ITI) therapy in hemophilia patients. High heterogeneity was revealed; therefore, it would be biased to rank interventions based on reported cost per QALY or ICUR. However, it is instructive and informative to collect all economic evaluation studies and summarize them in a table. The information on the table would in turn be used to redirect resources for efficient allocation. in general, it was revealed that preventive programs are cost effective interventions from different perspectives in Iran.